Keywords: ulcer, drugs, alcohol, study, found, glaxo, zantac
ULCER DRUGS & ALCOHOL
Article | 06 January 1992
A US study has found that Glaxo's Zantac (ranitidine) and SmithKline Beecham's Tagamet (cimetidine), but not Merck & Co's Pepcid (famotidine), ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
